Gestational Diabetes Mellitus – NSW, Australia Report

Exclusively available on Available only on IvyPanda® Made by Human No AI

Introduction

The online peer discussion has enhanced my internalization on the implications of Gestational Diabetes Mellitus (GDM), specifically in the context of NSW Australia. The online posts and peer discussion enabled me to gain insight as we were engaged in exchange of significant ideas on the topic under discussion. The contributions from each group member summed up to the development of the briefing document.

Gestational Diabetes Mellitus

The contributions from group members gave me a clear picture of GDM as a chronic disease, and the issues surrounding it. I gained the understanding that GDM is the disorder of carbohydrate intolerance mostly diagnosed in women who are expectant. During pregnancy, the body’s glucose metabolism is affected by the progesterone that is produced by cortisol, prolactin and the placenta. This interference is the main contributor to GDM. The demand of insulin in the body during pregnancy often increases starting from the second trimester. Given that most of the expectant women experience inadequate production of insulin, they often get hyperglycaemia as the growth and development of the foetus relies on the blood glucose. Conversely, high perinatal morbidity is associated with GDM. The condition is noted as a common complication that stems from GDM and its development corresponds to the development of pregnancy.

Gestational Diabetes Mellitus in the Context of NSW Australia

The group members’ contributions expanded my understanding of GDM in the context of Australia. GDM is prevalent in NSW Australia and its figures hit 4.7% in 2005. The group of women who are at a higher risk of infection are the indigenous women of which NSW makes about 8% of the total population.

The Implications of Gestational Diabetes Mellitus

With regard to this topic, the critical aspect is the fatal nature of GDM. It can possibly result in diabetes, which is a chronic disease. This leads to the risk of people developing multi-organ diseases. We had a deeper evaluation of the implications of GDM and we cited the inadequacy of resources and technology as the contributors of GDM. We all agreed that the nature of GDM calls for specialised care, which has not been realised much in the case of NSW Australia. Geographical isolation has contributed to the complexity of GDM, given that regional centres are far away from the remote communities. Expertise and medical equipment and supplies are among the inadequacies.

Prevention and Management of Chronic Disease Course

The online posts and peer discussion intensified our concern for the disorder, and we explored the current measures being employed in NSW Australia. Glucose monitoring through screening and management of the disease through patient education has been employed in NSW. Given that these initiatives have expanded the women’s understanding of GDM, we resorted to expound on patient education as it is the most successful approach. We decided to raise the awareness of GDM amongst midwifes, GPs, partners, patients and the public at large. This is a step seeking to reduce the chances of people developing type 2 diabetes and neonatal morbidity in WNSWLHD. I personally took the task of exploring the best prevention and management measures of GDM. I identified that universal screening should be done at intervals of 26-28 weeks with a 50g glucose load. In cases where the outcome turns out as positive, a glucose load of 75g OGTT should be administered. More so, women living in isolated areas should have better access to antenatal care. This should be the responsibility of telehealth consultants. The antenatal care team has to be supplied with additional aboriginal health workers to enhance support for the indigenous women during pregnancy. Furthermore, it is significant to have a better control of glycaemia so as to prevent neonatal morbidity. This implies that telehealth should monitor BGLs/ adequacy of diet regularly. Women who develop GDM should be subjected to OGTT within 6-8 weeks of post delivery. Additionally, they should be issued with letters informing them of the implications of GDM with regard to type 2 diabetes, and the significance of having OGTT. Reminder letters should be sent to patients in a bid to reinforce the significance of further testing. Distribution of brochures about GDM should also be included in obstetric practices, antenatal clinics and GP practices within WNSWLHD via the Division of General Practice.

More related papers Related Essay Examples
Cite This paper
You're welcome to use this sample in your assignment. Be sure to cite it correctly

Reference

IvyPanda. (2022, April 27). Gestational Diabetes Mellitus - NSW, Australia. https://ivypanda.com/essays/gestational-diabetes-mellitus-nsw-australia/

Work Cited

"Gestational Diabetes Mellitus - NSW, Australia." IvyPanda, 27 Apr. 2022, ivypanda.com/essays/gestational-diabetes-mellitus-nsw-australia/.

References

IvyPanda. (2022) 'Gestational Diabetes Mellitus - NSW, Australia'. 27 April.

References

IvyPanda. 2022. "Gestational Diabetes Mellitus - NSW, Australia." April 27, 2022. https://ivypanda.com/essays/gestational-diabetes-mellitus-nsw-australia/.

1. IvyPanda. "Gestational Diabetes Mellitus - NSW, Australia." April 27, 2022. https://ivypanda.com/essays/gestational-diabetes-mellitus-nsw-australia/.


Bibliography


IvyPanda. "Gestational Diabetes Mellitus - NSW, Australia." April 27, 2022. https://ivypanda.com/essays/gestational-diabetes-mellitus-nsw-australia/.

If, for any reason, you believe that this content should not be published on our website, please request its removal.
Updated:
This academic paper example has been carefully picked, checked and refined by our editorial team.
No AI was involved: only quilified experts contributed.
You are free to use it for the following purposes:
  • To find inspiration for your paper and overcome writer’s block
  • As a source of information (ensure proper referencing)
  • As a template for you assignment
Privacy Settings

IvyPanda uses cookies and similar technologies to enhance your experience, enabling functionalities such as:

  • Basic site functions
  • Ensuring secure, safe transactions
  • Secure account login
  • Remembering account, browser, and regional preferences
  • Remembering privacy and security settings
  • Analyzing site traffic and usage
  • Personalized search, content, and recommendations
  • Displaying relevant, targeted ads on and off IvyPanda

Please refer to IvyPanda's Cookies Policy and Privacy Policy for detailed information.

Required Cookies & Technologies
Always active

Certain technologies we use are essential for critical functions such as security and site integrity, account authentication, security and privacy preferences, internal site usage and maintenance data, and ensuring the site operates correctly for browsing and transactions.

Site Customization

Cookies and similar technologies are used to enhance your experience by:

  • Remembering general and regional preferences
  • Personalizing content, search, recommendations, and offers

Some functions, such as personalized recommendations, account preferences, or localization, may not work correctly without these technologies. For more details, please refer to IvyPanda's Cookies Policy.

Personalized Advertising

To enable personalized advertising (such as interest-based ads), we may share your data with our marketing and advertising partners using cookies and other technologies. These partners may have their own information collected about you. Turning off the personalized advertising setting won't stop you from seeing IvyPanda ads, but it may make the ads you see less relevant or more repetitive.

Personalized advertising may be considered a "sale" or "sharing" of the information under California and other state privacy laws, and you may have the right to opt out. Turning off personalized advertising allows you to exercise your right to opt out. Learn more in IvyPanda's Cookies Policy and Privacy Policy.

1 / 1